Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


PPRCH-33 - Epilepsy Management in Lebanon: Exploring Economic Burden, Quality of Life, and Cost-Effectiveness in the Context of Socioeconomic Challenges

  • At: Copenhagen (Denmark) (2025)
  • Type: Poster
  • Poster code: PPRCH-33
  • By: YOUNES, Samar (School of Pharmacy, Lebanese International University, Lebanon)
  • Co-author(s): Dr Samar Younes (School of Pharmacy, Lebanese International University, Bekaa, Lebanon / INSPECT-LB (Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban), Beirut, Lebanon / University of Limoges, EpiMaCT Epidemiology of Chronic Diseases in Tropical Zone, Limoges, France)
    Dr Nisreen Mourad (School of Pharmacy, Lebanese International University, Bekaa, Lebanon / INSPECT-LB (Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban), Beirut, Lebanon / University of Limoges, EpiMaCT Epidemiology of Chronic Diseases in Tropical Zone, Limoges, France / IVPN-Network, Fujairah, United Arab Emirates)
    Dr. Jalal Dahham (INSPECT-LB (Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban), Beirut, Lebanon / Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands)
    Prof. Pascale Salameh (INSPECT-LB (Institut National de Santé Publique, d'Épidémiologie Clinique et de Toxicologie-Liban), Beirut, Lebanon / Faculty of Pharmacy, Lebanese University, Beirut, Lebanon / Department of Primary Care and Population Health, University of Nicosia Medical School, Nicosia, Cyprus / School of Medicine, Lebanese American University, Byblos, Lebanon)
    Prof. Clémence Thébaut (University of Limoges, EpiMaCT Epidemiology of Chronic Diseases in Tropical Zone, Limoges, France)
  • Abstract:

    Introduction
    Epilepsy management in Lebanon faces significant challenges amid the country's ongoing economic crisis, with limited research integrating pharmacoeconomic evaluations, medication quality awareness, and patient-reported outcomes. Existing studies suffer from geographical limitations, small sample sizes, and insufficient exploration of..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 September 2025

FIP Congresses